---
title: "Maccura obtained a medical device registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243083270.md"
description: "According to the Zhitong Finance APP, Maccura announced that the company recently received the \"Medical Device Registration Certificate\" (in vitro diagnostic reagents) issued by the National Medical Products Administration, with the product name being the ABO blood type reverse typing red blood cell reagent kit"
datetime: "2025-06-04T10:38:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243083270.md)
  - [en](https://longbridge.com/en/news/243083270.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243083270.md)
generator: "portal-rs"
---

# Maccura obtained a medical device registration certificate

According to the Zhitong Finance APP, Maccura (300463.SZ) announced that the company recently received the "Medical Device Registration Certificate" (in vitro diagnostic reagents) issued by the National Medical Products Administration, with the product name being the red blood cell reagent kit for human ABO blood type reverse typing

### Related Stocks

- [300463.CN](https://longbridge.com/en/quote/300463.CN.md)

## Related News & Research

- [REG - Harwood Capital Mgmt Odyssean Inv. Trust Gooch & Housego PLC - Form 8.3 - Gooch & Housego plc](https://longbridge.com/en/news/297792293.md)
- [Mexico's Ebrard and US' Lutnick meet on sidelines of G20](https://longbridge.com/en/news/297792146.md)
- [Protector Forsikring insider Heikkilä buys 129 shares at NOK 470.57, holding rises to 2,050](https://longbridge.com/en/news/297776876.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)
- [22:00 ETCarestream Healthcare International améliore le détecteur DRX-LC pour améliorer les performances d'imagerie de grande longueur](https://longbridge.com/en/news/297978656.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**